Blog - Page 22 of 29

Germany Italy Spain Sweden UK USADECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big data Project type: Preclinic Clinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.1. – Understanding health; wellbeing and disease Participating agents: FUNDACIO HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA Keywords: rheumatology; autoimmunity; IMIDs; inflammatory bowel disease; biomarker; lupus; psoriasis...

Belgium Denmark France Germany Ireland Italy Latvia Netherlands Spain Sweden Switzerland UK USAEUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big Data DRUG Project type: Clinic Project target: Infectious Disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSIDAD CARLOS III DE MADRID Keywords: drug discovery; AI; diabetes; tuberculosis; oral drug; infectius disease; clinical trial Countries:...

France Germany Nehterlands SwitzerlandLong-range electrodynamic INteractions between proteinS

July 19, 2022by pcdata

Dates: 01/09/2021 31/08/2025 Topic: Tool Project type: Preclinic Project target: Other Financing: H2020-EU.1.2. – EXCELLENT SCIENCE – Future and Emerging Technologies (FET) H2020-EU.1.2.1. – FET Open Participating agents: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS Keywords: protein; biosensor; cell biology; biophysic; LEDIs; electrodynamic interactions Countries: France; Switzerland; Germany; Nehterlands Project page: Access page

IsraelRevealing the immune tumor microenvironment (iTME) in melanoma by multiplexed imaging

July 19, 2022by pcdata

Dates: 01/01/2021 31/12/2025 Topic: Tool Project type: Preclinic Immunotherapy Theranostic Project target: Skin Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: WEIZMANN INSTITUTE OF SCIENCE Keywords: oncology; melanoma; tumour; protein; immunotherapy; Itme; microenviroment; machine learning; platform Countries: Israel Project page: Access page

Belgium Netherlands SwedenProof of Principle of the best-in-class therapeutic mRNA cancer vaccine

July 19, 2022by pcdata

Dates: 01/02/2021 31/07/2025 Topic: Tool Project type: Clinic Theranostic Immunotherapy Project target: Cancer Vaccines Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Other Participating agents: ETHERNA IMMUNOTHERAPIES Keywords: vaccine; oncoology; HPV16; RNA; Countries: Belgium; Sweden; Netherlands Project page: Access page

France Germany SpainWell-Aging and the Tanycytic Control of Health

July 19, 2022by pcdata

Dates: 01/03/2019 28/02/2026 Topic: Biomarkers identification Project type: Preclinic Project target: Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: aging; neurobiology; glial cell; obesity; homeostasis; biomarker; tanycyte Countries: France; Spain; Germany Project page: Access page

France USATargeted strategies for prevention and treatment of fibrosis-associated liver cancer

July 19, 2022by pcdata

Dates: 01/07/2022 30/06/2027 Topic: Biomarkers identification Project type: Preclinic Project target: Liver cancer Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE THE UNIVERSITY OF TEXAS SYSTEM Keywords: liver cancer; oncology; tumour; cihrosis; biomarker; hepatology; HCC; claudin-1; Countries: France; USA Project...

France Greece Ireland Italy Netherlands Norway Spain Sweden Switzerland UK USANEw Clinical Endpoints in primary Sjögrens Syndrome: an Interventional Trial based on stratifYing patients

July 19, 2022by pcdata

Dates: 01/01/2019 31/12/2024 Topic: Biomarkers identification Project type: Clinic Preclinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: Countries: France; UK; Sweden; Netherlands; Spain; Greece; Ireland; Norway;...

CyprusMechanical Biomarkers for Prediction of Cancer Immunotherapy

July 19, 2022by pcdata

Dates: 01/04/2020 31/03/2025 Topic: Biomarkers identification Project type: Immunotherapy Preclinic Clinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSITY OF CYPRUS Keywords: biomarker; oncology; tumour; immunotherapy; model; biomechanic Countries: Cyprus Project page: Access page

Germany Poland UKSANO: Centre for New Methods in Computational Diagnostics and Personalised Therapy

July 19, 2022by pcdata

Dates: 01/08/2019 31/07/2026 Topic: Research Centre AI/Big Data Project type: Preclinic Project target: Other Financing: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions Participating agents: SANO CENTRUM ZINDYWIDUALIZOWANEJ MEDYCYNY OBLICZENIOWEJ MIEDZYNARODOWA FUNDACJA BADAWCZA Keywords: data science; productivity; catalysis; digital tool; centre; biomarker; AI Countries: Poland; Germany; UK Project page: Access page...

Newer Posts

Older Posts